CLINIPHAR: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CLINIPHAR
Largest movements
- Tangible fixed assets +€43,113
up €43,113 (+2.1%), from €2.0m to €2.1m
of which Land and buildings: +€57,525
- Cash -€28,427
down €28,427 (-29.9%), from €95,211 to €66,783
mainly Investment in fixed assets (net) (-€95,685) and Debts after one year (-€29,338)
- Reserves +€65,315
up €65,315 (+2.7%), from €2.5m to €2.5m
of which Distributable reserves: +€65,315
- Debts after one year -€29,338
down €29,338 (-37.7%), from €77,921 to €48,584
- Gross operating margin +€9,277
up €9,277 (+5.9%), from €156,327 to €165,604
- Taxes -€2,601
down €2,601 (-7.7%), from €33,723 to €31,121
- Financial charges -€1,734
down €1,734 (-25.6%), from €6,776 to €5,042
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,613,261 | €2,625,347 | +€12,086 | +0.5% |
| Fixed assets | 21/28 | €2,036,499 | €2,079,613 | +€43,113 | +2.1% |
| Tangible fixed assets | 22/27 | €2,036,299 | €2,079,413 | +€43,113 | +2.1% |
| Land and buildings | 22 | €1,976,859 | €2,034,384 | +€57,525 | +2.9% |
| Plant, machinery and equipment | 23 | €12,434 | €12,216 | -€218 | -1.8% |
| Furniture and vehicles | 24 | €47,006 | €32,813 | -€14,193 | -30.2% |
| Financial fixed assets | 28 | €200 | €200 | = | 0.0% |
| Current assets | 29/58 | €576,762 | €545,734 | -€31,028 | -5.4% |
| Amounts receivable within one year | 40/41 | €168,910 | €188,892 | +€19,982 | +11.8% |
| Trade receivables | 40 | €83,341 | €82,255 | -€1,086 | -1.3% |
| Other amounts receivable | 41 | €85,569 | €106,637 | +€21,068 | +24.6% |
| Current investments | 50/53 | €309,220 | €285,687 | -€23,533 | -7.6% |
| Cash at bank and in hand | 54/58 | €95,211 | €66,783 | -€28,427 | -29.9% |
| Deferred charges and accrued income | 490/1 | €3,421 | €4,372 | +€951 | +27.8% |
| Total equity and liabilities | 10/49 | €2,613,261 | €2,625,347 | +€12,086 | +0.5% |
| Equity | 10/15 | €2,470,875 | €2,536,190 | +€65,315 | +2.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €2,452,275 | €2,517,590 | +€65,315 | +2.7% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Other | 1319 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €2,450,415 | €2,515,730 | +€65,315 | +2.7% |
| Amounts payable | 17/49 | €142,386 | €89,157 | -€53,229 | -37.4% |
| Amounts payable after more than one year | 17 | €77,921 | €48,584 | -€29,338 | -37.7% |
| Financial debts | 170/4 | €77,921 | €48,584 | -€29,338 | -37.7% |
| Amounts payable within one year | 42/48 | €64,464 | €40,573 | -€23,891 | -37.1% |
| Current portion of amounts payable after more than one year | 42 | €53,759 | €29,338 | -€24,422 | -45.4% |
| Trade debts | 44 | €7,054 | €7,015 | -€38 | -0.5% |
| Suppliers | 440/4 | €7,054 | €7,015 | -€38 | -0.5% |
| Taxes, remuneration and social security | 45 | €3,589 | €4,081 | +€492 | +13.7% |
| Taxes | 450/3 | €3,589 | €4,081 | +€492 | +13.7% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €62 | €139 | +€77 | +123.8% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €52,422 | €52,572 | +€149 | +0.3% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €4,380 | €5,871 | +€1,491 | +34.0% |
| Other operating charges | 640/8 | €6,528 | €7,878 | +€1,350 | +20.7% |
| Gross operating margin | 9900 | €156,327 | €165,604 | +€9,277 | +5.9% |
| Operating profit (loss) | 9901 | €92,996 | €99,284 | +€6,287 | +6.8% |
| Financial income | 75/76B | €3,647 | €2,195 | -€1,452 | -39.8% |
| Recurring financial income | 75 | €3,647 | €2,195 | -€1,452 | -39.8% |
| Financial charges | 65/66B | €6,776 | €5,042 | -€1,734 | -25.6% |
| Recurring financial charges | 65 | €6,776 | €5,042 | -€1,734 | -25.6% |
| Profit (loss) for the period before taxes | 9903 | €89,867 | €96,436 | +€6,569 | +7.3% |
| Income taxes | 67/77 | €33,723 | €31,121 | -€2,601 | -7.7% |
| Profit (loss) for the period | 9904 | €56,144 | €65,315 | +€9,170 | +16.3% |
| Profit (loss) for the period to be appropriated | 9905 | €56,144 | €65,315 | +€9,170 | +16.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.